...
首页> 外文期刊>Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism >Quantification of 5-HT2A receptors in the human brain using (18F)altanserin-PET and the bolus/infusion approach.
【24h】

Quantification of 5-HT2A receptors in the human brain using (18F)altanserin-PET and the bolus/infusion approach.

机译:使用(18F)altanserin-PET和推注/输注方法对人脑中5-HT2A受体进行定量。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study is to describe and validate a method for accurate quantification of 5-hydroxytryptamine (5-HT)(2A) receptors using [18F]altanserin-positron emission tomography (PET) and the bolus/infusion approach. A bolus/infusion ratio of 1.75 h aimed at attaining rapid steady state in blood and brain was predicted from previous bolus studies performed in our laboratory. The infusion schedule was tested in normal subjects (n = 10) using dynamic PET and frequent plasma sampling for 6 h. Steady state was attained in brain and plasma within 2 h, and time-activity curves remained constant for another 3 h. To represent free and nonspecifically bound [18F]altanserin and its radiolabeled metabolites only, cerebellum must show no displacement in 5-HT(2A) displacement studies. To validate this, saturating doses of cold ketanserin were administered and it was found that specific binding of [18F]altanserin decreased uniformly to the level of the cerebellum and no change in the cerebellar time-activity curve was found after ketanserin administration. A shorter experimental setup was tested in a second group (n = 20) including patients with neuropsychiatric disorders. Dynamic PET (five frames of 8 minutes each) and venous blood sampling at midscan time started 2 h after [18F]altanserin administration. The mean percentage rate of change per hour in the outcome parameter, DV(3)', was low (mean -0.3% h-1; range -7.3-7.2% h-1) and no correlation of DV(3)' versus time was demonstrated. It is concluded that 5-HT(2A) receptor studies can be conducted within 2 h of [18F]altanserin infusion, yielding reliable results.
机译:本研究的目的是描述和验证一种使用[18F] altanserin-正电子发射断层扫描(PET)和推注/输注方法准确定量5-羟色胺(5-HT)(2A)受体的方法。根据我们实验室先前进行的推注研究,预计将达到1.75 h的推注/输注比,旨在达到血液和大脑的快速稳定状态。在正常受试者(n = 10)中使用动态PET和频繁的血浆采样6小时对输注时间表进行了测试。 2小时内大脑和血浆达到稳态,时间活动曲线又保持3小时不变。为了仅代表自由和非特异性结合的[18F] altanserin及其放射性标记的代谢物,小脑在5-HT(2A)置换研究中必须没有置换。为了证实这一点,给予了饱和剂量的冷酮色林,发现[18F] altanserin的特异性结合均匀地降低到小脑水平,并且在酮色林给药后未发现小脑时间活动曲线的变化。在第二组(n = 20)中测试了较短的实验设置,其中包括神经精神疾病患者。 [18F] altanserin给药后2小时,开始动态PET(5帧,每帧8分钟)和中扫描时静脉血采样。结果参数DV(3)'的每小时平均变化百分比较低(平均值-0.3%h-1;范围-7.3-7.2%h-1),并且DV(3)'与时间被证明了。结论是,可以在[18F] altanserin输注后2小时内进行5-HT(2A)受体研究,得出可靠的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号